<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04725955</url>
  </required_header>
  <id_info>
    <org_study_id>Harokopio_Hydroxytyrosol</org_study_id>
    <nct_id>NCT04725955</nct_id>
  </id_info>
  <brief_title>Postprandial Responses to Hydroxytyrosol-enriched Bread</brief_title>
  <official_title>Postprandial Responses of Healthy Subjects to Wheat Bread Enriched With Encapsulated Hydroxytyrosol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harokopio University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Harokopio University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The amelioration of postprandial glucose and insulin responses to bread is of great&#xD;
      importance since it may have significant beneficial effects on health. A number of studies&#xD;
      have shown that hydroxytyrosol may have positive metabolic effects. However, this compound&#xD;
      presents high hydrophilicity which constitutes the major barrier to its potential application&#xD;
      in foods. Microencapsulation arises as a technological strategy to protect it and increase&#xD;
      its stability. Alpha-cyclodextrin besides being a great carrier molecule, seems to also be&#xD;
      beneficial to postprandial glucose levels. Enrichment of bread with encapsulated&#xD;
      hydroxytyrosol could examine potential postprandial benefits.&#xD;
&#xD;
      Ten healthy normoglycemic subjects will participate in the study and will be provided with&#xD;
      either a solution of glucose (reference food) or white wheat bread or wheat bread enriched&#xD;
      with a-cyclodextrin or wheat bread enriched with hydroxytyrosol encapsulated in&#xD;
      a-cyclodextrin, with 1-week intervals in amounts that yielded 50 g of available&#xD;
      carbohydrates. Venous blood samples will be collected before consumption and at 30, 45, 60,&#xD;
      90, 120 and 180 min postprandially. Postprandial glucose, insulin and appetite-related&#xD;
      hormone responses as well as glycemic index (GI) and subjective appetite ratings will be&#xD;
      evaluated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 31, 2021</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycaemic Index</measure>
    <time_frame>Change between preprandial glucose measurements until 120 minutes postprandially</time_frame>
    <description>Glycaemic Index of the enriched breads</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin Response</measure>
    <time_frame>Change between preprandial insulin measurements until 180 minutes postprandially</time_frame>
    <description>Insulin Responses of the volunteers to the enriched breads (by a sandwich ELISA method, using a commercially available human insulin kit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appetite ratings</measure>
    <time_frame>Change between preprandial subjective appetite measurements until 180 minutes postprandially</time_frame>
    <description>Appetite ratings after the consumption of the enriched breads (evaluation of subjective appetite ratings, use of visual analogue scales)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Postprandial Responses</condition>
  <arm_group>
    <arm_group_label>Glucose Solution</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wheat bread enriched with a-cyclodextrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wheat bread enriched with hydroxytyrosol encapsulated in a-cyclodextrin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>White wheat bread</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enriched wheat bread</intervention_name>
    <description>Either 50g of glucose dissolved in 250mL water or white wheat bread or wheat bread enriched with 5mg a-cyclodextrin or wheat bread enriched with a 5mg mixture of a-cyclodextrin and encapsulated hydroxytyrosol (per 50g of available carbohydrates).</description>
    <arm_group_label>Glucose Solution</arm_group_label>
    <arm_group_label>Wheat bread enriched with a-cyclodextrin</arm_group_label>
    <arm_group_label>Wheat bread enriched with hydroxytyrosol encapsulated in a-cyclodextrin</arm_group_label>
    <arm_group_label>White wheat bread</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Normal body mass index&#xD;
&#xD;
          -  Stable body weight for at least 3 months before enrollment&#xD;
&#xD;
          -  Normal exercise, eating and drinking habits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
&#xD;
          -  Chronic medical illness (diabetes mellitus, cardiovascular disease, chronic liver,&#xD;
             kidney, polycystic ovary syndrome or untreated thyroid disease)&#xD;
&#xD;
          -  Use of nutritional supplements&#xD;
&#xD;
          -  History of drug and/or alcohol abuse&#xD;
&#xD;
          -  Psychiatric disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens</name>
      <address>
        <city>Athens</city>
        <state>Attiki</state>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harokopio University</investigator_affiliation>
    <investigator_full_name>Vaios T. Karathanos</investigator_full_name>
    <investigator_title>Professor of Food Engineering and Physical Chemistry</investigator_title>
  </responsible_party>
  <keyword>hydroxytyrosol</keyword>
  <keyword>a-cyclodextrin</keyword>
  <keyword>bread</keyword>
  <keyword>glycaemic index</keyword>
  <keyword>appetite</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

